Lu ZL - Search Results

1

Acetyl-macrocalin B suppresses tumor growth in esophageal squamous cell carcinoma and exhibits synergistic anti-cancer effects with the Chk1/2 inhibitor AZD7762.

Wang JN, Che Y, Yuan ZY, Lu ZL, Li Y, Zhang ZR, Li N, Li RD, Wan J, Sun HD, Sun N, Puno PT, He J. Wang JN, et al. Among authors: lu zl. Toxicol Appl Pharmacol. 2019 Feb 15;365:71-83. doi: 10.1016/j.taap.2019.01.005. Epub 2019 Jan 8. Toxicol Appl Pharmacol. 2019. PMID: 30633885

2

Transcriptome profiling of lncRNA and co-expression networks in esophageal squamous cell carcinoma by RNA sequencing.

Li Y, Shi X, Yang W, Lu Z, Wang P, Chen Z, He J. Li Y, et al. Tumour Biol. 2016 Oct;37(10):13091-13100. doi: 10.1007/s13277-016-5227-3. Epub 2016 Jul 23. Tumour Biol. 2016. PMID: 27449043

3

Integrated bioinformatics analysis of chromatin regulator EZH2 in regulating mRNA and lncRNA expression by ChIP sequencing and RNA sequencing.

Li Y, Luo M, Shi X, Lu Z, Sun S, Huang J, Chen Z, He J. Li Y, et al. Oncotarget. 2016 Dec 6;7(49):81715-81726. doi: 10.18632/oncotarget.13169. Oncotarget. 2016. PMID: 27835578 Free PMC article.

4

Prognostic alternative mRNA splicing signature in non-small cell lung cancer.

Li Y, Sun N, Lu Z, Sun S, Huang J, Chen Z, He J. Li Y, et al. Cancer Lett. 2017 May 1;393:40-51. doi: 10.1016/j.canlet.2017.02.016. Epub 2017 Feb 20. Cancer Lett. 2017. PMID: 28223168

5

Long non-coding RNA NKILA inhibits migration and invasion of non-small cell lung cancer via NF-κB/Snail pathway.

Lu Z, Li Y, Wang J, Che Y, Sun S, Huang J, Chen Z, He J. Lu Z, et al. J Exp Clin Cancer Res. 2017 Apr 17;36(1):54. doi: 10.1186/s13046-017-0518-0. J Exp Clin Cancer Res. 2017. PMID: 28412955 Free PMC article.

6

The therapeutic effects of Longikaurin A, a natural ent-kauranoid, in esophageal squamous cell carcinoma depend on ROS accumulation and JNK/p38 MAPK activation.

Che Y, Wang J, Yuan Z, Li Y, Lu Z, Zhang Z, Zhang J, Wan J, Sun H, Chen Z, Pu J, He J. Che Y, et al. Toxicol Lett. 2017 Oct 5;280:106-115. doi: 10.1016/j.toxlet.2017.08.005. Epub 2017 Aug 8. Toxicol Lett. 2017. PMID: 28801140

7

Immune signature profiling identified predictive and prognostic factors for esophageal squamous cell carcinoma.

Li Y, Lu Z, Che Y, Wang J, Sun S, Huang J, Mao S, Lei Y, Chen Z, He J. Li Y, et al. Oncoimmunology. 2017 Jul 31;6(11):e1356147. doi: 10.1080/2162402X.2017.1356147. eCollection 2017. Oncoimmunology. 2017. PMID: 29147607 Free PMC article.

8

Rabdocoestin B exhibits antitumor activity by inducing G2/M phase arrest and apoptosis in esophageal squamous cell carcinoma.

Wang J, Zhang Z, Che Y, Yuan Z, Lu Z, Li Y, Wan J, Sun H, Chen Z, Pu J, He J. Wang J, et al. Cancer Chemother Pharmacol. 2018 Mar;81(3):469-481. doi: 10.1007/s00280-017-3507-2. Epub 2018 Jan 8. Cancer Chemother Pharmacol. 2018. PMID: 29308536

9

TGF-β-induced NKILA inhibits ESCC cell migration and invasion through NF-κB/MMP14 signaling.

Lu Z, Chen Z, Li Y, Wang J, Zhang Z, Che Y, Huang J, Sun S, Mao S, Lei Y, Gao Y, He J. Lu Z, et al. J Mol Med (Berl). 2018 Apr;96(3-4):301-313. doi: 10.1007/s00109-018-1621-1. Epub 2018 Jan 29. J Mol Med (Berl). 2018. PMID: 29379981 Free PMC article.

10

Acetyl-macrocalin B, an ent-kaurane diterpenoid, initiates apoptosis through the ROS-p38-caspase 9-dependent pathway and induces G2/M phase arrest via the Chk1/2-Cdc25C-Cdc2/cyclin B axis in non-small cell lung cancer.

Wang JN, Zhang ZR, Che Y, Yuan ZY, Lu ZL, Li Y, Li N, Wan J, Sun HD, Sun N, Puno PT, He J. Wang JN, et al. Among authors: lu zl. Cancer Biol Ther. 2018 Jul 3;19(7):609-621. doi: 10.1080/15384047.2018.1449613. Epub 2018 May 8. Cancer Biol Ther. 2018. PMID: 29565730 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

536 results

Search Page